UPDATE : Thursday, June 20, 2019
상단여백
Merz’ check against Medytox: ‘Xeomin is the only pure toxin’
Apparently mindful of a rival botulinum toxin scheduled to be released in t...
by Jeong Sae-im  |  2019-03-18 15:03
라인
Hanmi’s US partner yanks BLA application for Rolontis after FDA demands more data
Spectrum, Hanmi Pharmaceutical’s U.S. partner, said Friday that it has resc...
by Lee Han-soo  |  2019-03-18 14:23
라인
Reimbursement for orphan drug Spinraza imminent
Biogen’s Spinraza (ingredient: nusinersen), a treatment for spinal muscular...
by Kim Yun-mi  |  2019-03-18 12:02
라인
Handok gets shares in TRIGR Therapeutics
Handok said Monday that it has invested $5 million to acquire shares in TRI...
by Lee Han-soo  |  2019-03-18 12:02
라인
Korean patients lack knowledge about risk of resistance development by BTX
More than half of the people who have undergone botulinum toxin (BTX) treat...
by Lee Han-soo  |  2019-03-15 15:39
라인
Dong-A ST slapped with ₩13.8 billion penalty for bribing doctors
The Ministry of Health and Welfare has ordered the suspension of reimbursem...
by Kwak Sung-sun  |  2019-03-15 15:38
라인
Theragen’s Lou Gehrig's disease treatment wins government support
Theragen ETEX said Friday that the Korea Drug Development Fund (KDDF) would...
by Lee Han-soo  |  2019-03-15 13:21
라인
SK Chemicals executive arrested for destroying evidence in humidifier sterilizers case
A high-ranking official at SK Chemicals has been arrested for trying to cov...
by Jeong Sae-im  |  2019-03-15 11:41
라인
Pharmbio Korea to develop antifungal drug with BioSynectics’ nanotechnology
Pharmbio Korea said Wednesday that it has signed a licensing-in deal with B...
by Lee Han-soo  |  2019-03-13 17:48
라인
Daewoong to enter P3 trial for Nabota in China
Daewoong Pharmaceutical said Wednesday that the China Food and Drug Adminis...
by Lee Han-soo  |  2019-03-13 15:43
라인
Regulator OKs Yuyu’s P2 clinical trial into dry eye treatment
Yuyu Pharmaceutical said Wednesday that the Ministry of Food and Drug Safet...
by Lee Han-soo  |  2019-03-13 12:43
라인
Tecentriq becomes 1st immunotherapy OKed for specific breast cancer
Roche said its PD-L1 (programmed death-ligand 1) inhibitor Tecentriq (ingre...
by Kim Yun-mi  |  2019-03-13 12:43
라인
GemVax & KAEL completes patient enrollment for P2 clinical trial into GV1001
GemVax & KAEL said Wednesday that it has completed patient registration for...
by Lee Han-soo  |  2019-03-13 10:49
라인
Dong-A ST’s erectile dysfunction treatment improves postmicturition dribbling
Dong-A ST said Monday that it has confirmed that Zydena (ingredient: Udenaf...
by Lee Han-soo  |  2019-03-12 18:02
라인
ImmuneOncia ends P1 clinical trials for solid cancer treatment
ImmuneOncia Therapeutics, a subsidiary of Yuhan Corp., said Tuesday that it...
by Lee Han-soo  |  2019-03-12 17:46
라인
Drugmakers to name new CEOs, enhance ownership
The pharmaceutical industry is expected to witness significant changes in m...
by Jeong Sae-im  |  2019-03-12 16:17
라인
Regulator OKs Humedix’s osteoarthritis treatment
Humedix said Monday that it has received sales approval for Humia, an osteo...
by Lee Han-soo  |  2019-03-12 13:55
라인
HanAll starts P3 clinical trials for dry eye treatment in US
HanAll Biopharma, a subsidiary of Daewoong Pharmaceuticals, said Tuesday th...
by Lee Han-soo  |  2019-03-12 10:41
라인
Kolon gets FDA nod for testing gene therapy for neuropathic pain
Kolon Life Science said Monday it obtained the U.S. Food and Drug Administr...
by Jeong Sae-im  |  2019-03-11 17:01
라인
LSK Global PS sets up subsidiary
LSK Global PS said Monday that it has established a subsidiary called LSK N...
by Lee Han-soo  |  2019-03-11 15:14
여백
여백
여백
Back to Top